Inhibikase Therapeutics Inc
NASDAQ:IKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
C
|
Crane Co
NYSE:CR
|
US |
|
Big 5 Sporting Goods Corp
NASDAQ:BGFV
|
US |
|
HeLIX Exploration PLC
OTC:HHEXF
|
UK |
|
H
|
Haverty Furniture Companies Inc
F:25F
|
US |
|
M
|
Melia Hotels International SA
SWB:MEL
|
ES |
|
P
|
Providence Resources PLC
LSE:PVR
|
IE |
|
T
|
Thai Beverage PCL
OTC:TBVPY
|
TH |
|
N
|
North American Construction Group Ltd
F:N5Z
|
CA |
|
Repro India Ltd
NSE:REPRO
|
IN |
|
A
|
Ascendas Real Estate Investment Trust
OTC:ACDSF
|
SG |
|
Black Iron Inc
TSX:BKI
|
CA |
|
Olaplex Holdings Inc
NASDAQ:OLPX
|
US |
|
Fortune Minerals Ltd
TSX:FT
|
CA |
|
Azucar Minerals Ltd
XTSX:MMX
|
CA |
|
R
|
Renta 4 Banco SA
MAD:R4
|
ES |
|
B
|
Brookdale Senior Living Inc
F:B7S
|
US |
|
S
|
Schlumberger NV
XMUN:SCL
|
US |
|
Team17 Group PLC
LSE:TM17
|
UK |
|
Z
|
Zip Co Ltd
ASX:ZIP
|
AU |
|
AT&T Inc
NYSE:T
|
US |
|
RLX Technology Inc
F:3CM
|
CN |
|
EVI Industries Inc
F:2YE
|
US |
|
Enphase Energy Inc
NASDAQ:ENPH
|
US |
Wall St Price Targets
IKT Price Targets Summary
Inhibikase Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
IKT is 5.99 USD with a low forecast of 3.03 USD and a high forecast of 8.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IKT's stock price target?
Price Target
5.99
USD
According to Wall Street analysts, the average 1-year price target for
IKT is 5.99 USD with a low forecast of 3.03 USD and a high forecast of 8.4 USD.